NEPH
NASDAQStockNephros, Inc.
$3.56-0.24 (-6.32%)
52-Week Range
$1.49
$5.79
Key Stats
Market Cap
—
P/E Ratio
—
Dividend Yield
—
Beta
1.48
Volume
34.9K
Avg Volume
30.5K
Performance
1M
+1.06%
3M
-21.81%
6M
-12.84%
YTD
-20.00%
1Y
+133.14%
3Y
+276.24%
5Y
-48.51%
Price Chart
ETF Exposure
NEPH is held by 10 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFSU | Dimensional - US Sustainability Core 1 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| VXF | Vanguard Extended Market ETF | 0.00% |
About NEPH ETF Exposure
Nephros, Inc. (NEPH) is held by 10 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $3.56. Investors can gain exposure to NEPH through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NEPH, sorted by portfolio weight.